Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...

How does the public feel about breakthrough technologies like AI, cell and gene therapy, cultivated meat, and new genomic ...

Scientists are gathering more evidence on which factor has more of an impact on human wellbeing amid the aging process.

MONTREAL, Québec, Canada, 18 February 2025 - A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman ...

Colorectal cancer (CRC), which affects the colon or rectum, represents a significant public health challenge. It ranks as the ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and ...

Hasbro unveiled a new strategic plan for growth on Thursday —but did not unveil the location of its new headquarters, which ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Sex hormones have a profound impact on the brain, affecting disorders like stroke, epilepsy, and Alzheimer’s. A new review ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immun ...